Orphenadrine Citrate, Aspirin and Caffeine

Product NDC
71993-999
11-digit product format
719930999
Labeler code
71993
Product ID
71993-999_9bbb2502-f443-eebb-e053-2a95a90aa47b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Orphenadrine Citrate, Aspirin and Caffeine
Dosage form
TABLET
Route
ORAL
Labeler
Atland Pharmaceuticals, LLC
Application
ANDA075141
Marketing category
ANDA
Marketing start
2019-06-21
Marketing end
0000-00-00
Substance
ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
Active strength
50 mg/1; mg/1; mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71993-999-60EA - Each71993-99909e4eee6-ebab-4f44-beec-db4eed2687ec12019-09-05